Speak with one of our advisors: 0800 085 6663 or
 

For news on events which Check4Cancer are hosting, attending or exhibiting at, please click here

July, 2020

Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, is reopening its SkinHealth SkinCheck clinics following enforced closure due to COVID-19. The clinics are now open, with additional safety precautions in place, to provide a thorough skin cancer examination and mole check for anyone concerned about a specific mole or new skin changes.

July, 2020

The first of three articles in LaingBuisson Healthcare Markets by Professor Gordon Wishart  and Philip Housden, managing director of Housden Group on the effect of the Covid pandemic and lockdown on the relationships between the NHS, insurers and independent providers.

July, 2020

 

Professor Gordon Wishart, our Chief Medical Officer comments on the recently published journal ‘Infectious Agents & Cancer- supporting the case for universal HPV vaccination’ and states; ''this systematic review of 26 studies concludes that is it highly likely that high-risk HPV has a causal role in the development of prostate cancer.''

July, 2020

 

Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, announces audit results from its private breast cancer diagnostic pathway, confirming Check4Cancer’s One Stop Breast Clinic network provides clinical excellence for patients experiencing symptoms of breast cancer.

July, 2020

Professor Gordon Wishart, our Chief Medical Officer speaks with The Daily Mail on the current cancer crisis which has seen urgent cancer referrals wrongly turned down during COVID-19. 

July, 2020

Professor Gordon Wishart, Chief Medical Officer at Check4Cancer, an early cancer detection company, and Visiting Professor of Cancer Surgery at Anglia Ruskin School of Medicine.  

A report from University College London has documented a reduction in GP referrals of 70-89% in England and Northern Ireland in April 2020, due to the pandemic and lockdown restrictions (1).

June, 2020

Leading clinicians, including our Chief Medical Officer, Professor Gordon Wishart have written to Boris Johnson warning the UK faces a ‘second health catastrophe’’ because so many non-Covid patients are missing out on diagnosis and treatment as a result of the pandemic. 

June, 2020

As the Covid-19 pandemic continues to cause disruption across the country, it is likely that you will have seen delays and cancellations to your usual GP and outpatient appointments. With no clear end in sight, it may be some time before NHS services are able to return to normal.

June, 2020

Professor Gordon Wishart, Chief Medical Officer at Check4Cancer discusses how at-home HPV testing for cervical cancer screening could prevent further harm caused by suspension of NHS services during the pandemic. 

June, 2020

Professor Gordon Wishart, our Chief Medical Officer discusses with ITV News the impact of COVID-19 on cancer diagnosis and treatment.

June, 2020

Gordon Wishart, our Chief Medical Officer comments in 'The Sunday Express' that the early increase in cancer deaths will be to do with delays or cancellations of crucial treatments such as chemotherapy.  Over the next 12 months we will see the devasting impact of delays in screening and diagnosis and the number of patients with undiagnosed or untreated cancer is growing and will result in increased deaths and huge anxiety to patients affected.  Read the article in full here https://bit.ly/2YqKBNF

 

June, 2020

Gordon Wishart, our Chief Medical Officer comments in 'The Sunday Express' that delays in cancer diagnosis lead to patients ultimately requiring more treatment and having a worse prognosis and in some cases lost chances of survival.  Read the full article here https://bit.ly/3dpPGvU

June, 2020

Professor Gordon Wishart, our Chief Medical Officer comments on the news that COVID-19 death rates fall below cancer death rates for week ending 22 May 2020. 

June, 2020

If you have any concerns about a specific mole or any new skin changes, then Check4Cancer can provide you with fast track access to our Skin Diagnosis Clinics via our SkinHealth network.

May, 2020

 

Check4Cancer’s bowel cancer screening tests are available and can be delivered direct to your door. BowelCheck is a simple test at-home Quantitative Faecal Immunochemical Test (qFIT) which takes minutes and will give you results in just 5 working days.

May, 2020

 

You’ve got the time, you’ve got the knowledge, have you got the confidence to take control of your prostate cancer checking whilst in lockdown?

May, 2020

We know embarrassment causes missed smear test appointments, but it’s time to hang up your hang-ups and seize lockdown as an opportunity to take control of your own cervical cancer check.

May, 2020

With some cancer treatment still on hold as the NHS focuses on tackling the Covid-19 outbreak, fears are growing over the impact on patient outcomes. Maria Davies of LaingBuisson talks to our Chief Medical Officer, Professor Gordon Wishart about the need to maintain essential diagnostics and treatment in a time of crisis. 

Read the article in full here https://bit.ly/35VpdTJ

 

May, 2020

Over 80% of all skin cancers are caused by over-exposure to UV radiation from the sun and/or sunbeds. This means that the majority of all skin cancers are preventable by undertaking simple sun safety measures. In this final blog in this series for Sun Awareness Week, we explore the measures you can take to protect your skin and reduce your chances of getting skin cancer.

May, 2020

Skin cancer is the most common form of cancer in the UK, however, 86% of skin cancers can be prevented and there is a 98% survival rate if skin cancer is caught early versus 16% if caught late.  In this blog, the third in our series for Sun Awareness Week, we explore why you should get tested for skin cancer.

May, 2020

 

Skin cancer is the most common form of cancer in the UK, however, there is a 98% survival rate if skin cancer is caught early.  How do you know if you have skin cancer? In this blog, the second in our series for Sun Awareness Week, we explore the signs and symptoms of skin cancer.

May, 2020

Skin cancer is the most common form of cancer in the UK and rates of skin cancer are increasing faster than any other cancer in the UK, with figures doubling every 10-20 years¹. Over 80% of all skin cancers are caused by over-exposure to UV radiation from the sun and/or sunbeds. This means that the majority of all skin cancers are preventable by undertaking simple sun safety measures.

May, 2020

Failure to fully integrate NHS and private hospitals during the COVID-19 pandemic will increase cancer death rates according to our Chief Medical Officer, Professor Gordon Wishart.

April, 2020

Professor Wishart, our Chief Medical Officer has written an article in ecancer about how failure to fully integrate NHS and private hospitals during the COIVID-19 pandemic will increase cancer death rates.

Professor Wishart states that we need to act now to find ways to use the resources currently lying fallow in private hospitals to diagnose patients with suspicious cancer symptoms and treat all urgent cancer cases. If we fail, then the NHS will not be able to cope with the overwhelming demand after the lockdown and many patients will die during the next five years as a result of a delay in diagnosis or suboptimal cancer treatment.

The article can be read in full here https://bit.ly/3cyRFNr

 

 

April, 2020

With regular screening, 25% fewer people die from bowel cancer. How can you get screened? What are the different types of test available and how do they work? In the final blog in this series for Bowel Cancer Awareness Month, we explore how bowel cancer screening works and what to expect.

April, 2020

Early detection of bowel cancer saves lives. The number of people dying of bowel cancer has been falling since the 1970s, and this may be due to earlier diagnosis and better treatment[1].

In our third blog for Bowel Cancer Awareness Month, we look at the reasons why you should get tested for bowel cancer and the benefits of cancer screening.

April, 2020

Professor Wishart, our Chief Medical Officer has written an article in ecancer about how cancer treatment delays could increase death rates due to the impact of COVID-19 pandemic on UK hospital capacity.

April, 2020

Check4Cancer is providing fast-track access to our national network of ‘OneStop Breast Clinics’ located in London and throughout the UK during the COVID-19 pandemic. 

April, 2020

Professor Gordon Wishart was interviewed on The Today Programme on BBC Radio 4  discussing the impact of the coronavirus pandemic on cancer diagnosis and treatment.

April, 2020

Over 42,000 people are diagnosed with bowel cancer every year in the UK[1]. How do you know if you’ve got bowel cancer? In this blog, the second in our series for Bowel Cancer Awareness Month, we explore the signs and symptoms of bowel cancer.

March, 2020

Professor Gordon Wishart, Chief Medical Officer of Check4Cancer launches a private ‘OneStop Breast Clinic’ for younger patients who will no longer be seen in NHS breast clinics.

March, 2020

 

Bowel cancer is the fourth most common cancer in the UK and the second biggest cancer killer, but it shouldn’t be.  If bowel cancer is detected at its earliest stages, there is a greater than 90% of curing it. In recognition of Bowel Cancer Awareness Month this April, Check4Cancer is sharing a series of blogs exploring the WHO, WHAT, WHY and HOW of bowel cancer. In our first blog, we explore the question: who is at risk of bowel cancer?

March, 2020

Prostate cancer survival is improving and has tripled in the last 40 years in the UK, probably because of PSA testing[1]. When diagnosed at its earliest stage, all (100%) people with prostate cancer will survive their disease for five years or more, compared with around 1 in 2 (49%) people when the disease is diagnosed at the latest stage. In the final blog in this series for Prostate Cancer Awareness Month, we discuss how you can get tested for prostate cancer, exploring the different types of test available and how they work.

March, 2020

Prostate cancer is the most common cancer in men, however it’s often symptomless in its early stages. In our third blog for Prostate Cancer Awareness Month, we look at the reasons why you should get tested for prostate cancer and the benefits of cancer screening.

March, 2020

More than 47,000 men are diagnosed with prostate cancer in the UK every year– that’s around 130 every day[1]. Prostate cancer is caused when cells in the prostate gland grow abnormally and form lumps called tumours. How do you know if you’ve got prostate cancer? In this blog, the second in our series for Prostate Cancer Awareness Month, we explore the symptoms of prostate cancer.

March, 2020

March is Prostate Cancer Awareness Month. In recognition of this, Check4Cancer is sharing a series of blogs exploring the WHO, WHAT, WHY and HOW of prostate cancer. In our first blog, we explore the question: who is at risk of prostate cancer?

In the UK, about 1 in 8 men will be diagnosed with prostate cancer in their lifetime1, and it is the second most common cause of cancer deaths in men in the UK. Although the exact cause is unknown, there are several risk factors that can increase your chances of getting prostate cancer. The three main risk factors are age, family history and ethnicity.

January, 2020

 

Tuesday 4th February is World Cancer Day, Professor Gordon Wishart, our Chief Executive Officer and Chief Medical Officer talks about cancer prevention, read more here. 

January, 2020

Professor Gordon Wishart, our CEO and Chief Medical Officer comments on the 54% increase in cervical cancer rates in women aged 25-29 as reported by Cancer Research UK. 

January, 2020

The Guardian has reported today that experts say that cervical cancer could be eliminated in England. Vaccination and HPV screening could potentially end the disease, NHS England says. 

 

September, 2019

Investing in early cancer diagnosis can play a big part in closing the survival gap.

September, 2019

A Scottish landmark research study presented this week at the 2019 World Conference on Lung Cancer has confirmed that the EarlyCDT lung blood test can increase the diagnosis of early stage lung cancer by more than 50%.

July, 2019

Cancer Research UK has recently reported that the incidence of melanoma, the most serious type of skin cancer, has risen by 45% in the ten year period between 2004-2006 and 2014-2016 and, in the last year 500,000 people have been referred for investigation of a suspicious skin lesion.

June, 2019

Cervical cancer is nearly always preventable. HPV (Human papillomavirus) is a sexually transmitted virus that is extremely common - with four in five people exposed to the virus at some point in their lives. It is also the leading cause of cervical cancer in women, with 99.7% of cervical cancers being caused by HPV. The use of vaccination can prevent approximately 70% of all cervical cancer, while regular cervical screening can prevent nearly all cervical cancers by detecting any abnormal cells at an early stage before the cells turn cancerous.

February, 2019

First long-term study (FH02) from University of Manchester confirming effectiveness of annual screening mammography from age 35-39 for women at moderate or high risk of developing breast cancer. 80% of invasive cancers detected were less than 2cm, and 80% had not spread to lymph nodes. We will be updating our risk stratified breast screening protocol at Check4Cancer in light of these data.

November, 2018

Prostate cancer is the most common cancer in men, with 1 in 8 diagnosed at some point in their lives. Indeed, with Men’s Health Awareness Month underway, the importance of tackling this prevalent disease is, quite rightly, capturing public attention.

November, 2018

The PREDICT breast cancer survival and treatment prediction model won the People's Choice Award at the Office for National Statistics (ONS) Research Excellence Awards on 22 November 2018.

November, 2018

A finalist in the 'Rising Star' category of the LaingBuisson Health & Care Awards 2018.  Under Professor Gordon Wishart's clinical leadership as Chief Medical Officer, and his handpicked Clinical Advisory Committee, Check4Cancer has become a trusted advisor to private medical insurance companies and the corporate sector, with the development of audited direct referral diagnostic pathways for breast cancer & skin cancer for insured members.  

November, 2018

A recent US study published in Obstetrics & Gynecology has confirmed the prevalence of high-risk HPV types detected by self-collected cervical swab kits was not different to that detected by clinicians during pelvic examination. Furthermore, all patients found to have a high-grade cervical cancer had a HPV-positive self-collection result. This study confirms the contribution that home testing for HPV can can make to cervical cancer screening, and supports the GynaeCheck screening programme pioneered by Check4Cancer in the UK during the last 4 years.Read the study here.

November, 2018

AXA PPP healthcare has teamed up with screening service, Check4Cancer, to enhance its prostate cancer diagnosis pathway. The new screening process will help fast-track members with suspected prostate cancer so that they undergo a detailed MRI of the prostate before undergoing a biopsy.

June, 2018

Professor Gordon Wishart, Chief Medical Officer of Check4Cancer, presents audit results from its private breast cancer diagnosis pathway to the Association of Breast Surgery annual conference in Birmingham today. 

June, 2018

Professor Gordon Wishart, Chief Medical Officer at Check4Cancer comments on yesterday's front page Telegraph article ("Holy Grail" cancer blood test) which suggests that this blood test could be used for cancer screening in the NHS within 5 years.

May, 2018

Check4Cancer is delighted to announce the appointment of Louise Mills as Director of Clinical Services.

May, 2018

Private providers of screening mammograms such as BreastHealth UK (www.breasthealthuk.com) are expecting a surge in requests from women who do not want to wait up to 6 months for their mammogram.

February, 2018

By working closely with large corporate clients and UK private medical insurance companies, Check4Cancer has been able to modernise the delivery of private cancer diagnostic services to suit the changing private and corporate markets, while improving patient-focused outcomes related to their clinical care.

 Could this be our year? Check4Cancer has been shortlisted as one of four finalists in the category 'Diagnostics provider of the year' at the Healthcare Investor Awards 2018.

 The 2018 Health Investor Awards will be presented on 13th June in London.

November, 2017

Cambridge Magazine features Professor Gordon Wishart and the Check4Cancer team talking about MyBreastRisk, the first DNA saliva test that predicts a woman's personal breast cancer risk.

Click here for Cambridge Magazine (pages 32-33) 

October, 2017

‘How safe is your operation’ (BBC Panorama, 16.10.17) questions safety of surgical procedures in private sector.

Prof. Wishart, CMO at Check4Cancer discusses whether failures in clinical governance are restricted to the private sector.

October, 2017

BreastHealth UK, part of the Check4Cancer group, launches MyBreastRisk - the first commercially available test that combines both genetic and lifestyle factors to determine a woman’s personal lifetime breast cancer risk.

September, 2017

The Paterson debacle will have damaged public confidence in private breast cancer diagnostics. 

In response, Check4Cancer CMO Prof Gordon Wishart has established a national network of OneStop breast cancer clinics via it's BreastHealth UK brand, where patients can be assured of receiving an accurate diagnosis in a timely fashion. The diagnostic pathway is recorded online to ensure compliance with best practice and professional guidelines. 

This network is now being used by several UK Private Medical Insurance companies to increase their clinical governance and accountability, and is now seeing an increasing number of non-insured patients also.

Read more: Ian Paterson - Victims of disgraced surgeon get £37m

 

September, 2017

Rising Star Healthcare Outcomes Copy Innovation in Technology

Check4Cancer is delighted to have been shortlisted as finalist in three separate categories of the Laing Buisson healthcare awards for excellence 2017.

Rising Star -  Professor Gordon Wishart, as Chief Medical Officer of Check4Cancer, has led the company to becoming an innovative private provider of early cancer detection services with cancer as its sole-focus and in doing so has created the perfect vehicle to make a major impact on early cancer detection in the UK.

Healthcare outcomes -  Check4Cancer's tangible successes include the introduction of breast cancer and skin cancer self-referral diagnostic pathways ensuring fast and accurate diagnosis.

Innovation in technology -  Check4Cancer's Cancer Impact Calculator, a custom-built model, helps employers to measure the impact of company-paid cancer screening for employees.

 

The awards will be presented on 15 November in London. LaingBuisson healthcare awards for excellence 2017

July, 2017

Professor Dame Sally Davies, Chief Medical Officer for England, calls for Whole Genome Sequencing to be offered to all cancer patients.

Prof Dame Sally Davies’, annual report was published on the 4th July 2017 calling for Whole Genome Sequencing (WGS) to be offered to all cancer patients. WGS analyses an individual’s entire genome; looking at all 20 000 genes as well as the “packaging material” known as introns. Genomic testing can be used to target cancer treatment and prevention.

April, 2017

A cancer diagnosis leads to a ripple effect across an entire organisation, presenting particular challenges in terms of people management. Check4Cancer has commissioned a report to help HR Managers get to grips with the real impact that cancer can have on businesses across the UK.

March, 2017

Check4Cancer and Cigna have been working together for the past 14 months to tackle early detection of breast cancer and skin cancer.

Cigna teamed up with BreastHealth UK, in January 2016 to provide OneStop breast cancer diagnostics and with SkinHealth UK in June 2016 to offer customers rapid access to skin cancer specialists across the UK.

BreastHealth UK and SkinHealth UK are part of Check4Cancer Ltd.

 We are proud to announce that for the second year running Check4Cancer and Cigna UK have been shortlisted for ‘Diagnostics care provider of the year’. For more information please see: Health Investor Awards 2017.

October, 2016

ONCOassist app adds PREDICT algorithm, licensed from Cambridge Enterprise, to help doctors make critical treatment decisions following breast cancer surgery

Chief Medical Officer at Check4Cancer, Prof Gordon Wishart led a team of clinicians and scientists to develop the PREDICT survival and treatment benefit model.

September, 2016

Check4Cancer will be exhibiting at the largest dedicated reward and benefits event in Europe – Employee Benefits Live 

EB Live Olympia Logo

Check4Cancer will be exhibiting at the largest dedicated reward and benefits event in Europe - Employee Benefits Live on 11th and 12th October 2016 at Olympia London. 

July, 2016

With schools having broken up for the summer holidays and long days ahead, it’s more important then ever for parents to consider the impact of sun damage on their children – as a recent story reported in the Daily Mail has brought home.

Jennifer Nicholson, 50, spoke of her heartbreak after her 18-year-old daughter, Freja, died of skin cancer as a result of childhood holidays in the sun. The mother blamed herself for not always applying sunscreen to her daughter's fair skin during the hot British summers of her childhood. Doctors said if she had, Freja might still be alive.

July, 2016

Great strides have been made in the detection and treatment of cervical cancer since the national Cervical Screening Programme in 1988, with an estimated 100,000 lives having been saved by 2012. Now, our understanding of the connection with a sexually acquired virus is helping to make cervical cancer an almost entirely preventable disease.

Jullien Brady – Clinical Advisor for GynaeCheck and Check4Cancer – is also a Consultant Obstetrician and Gynaecologist at Bedford Hospital, with extensive experience in the UK cervical screening programme. He explains: “Cervical cancer is effectively a sexually transmitted disease. We now know that almost all cases are caused by exposure to certain strains of human papillomavirus, or HPV.

July, 2016

A major new study – the largest of its kind ever undertaken – has been hailed as a milestone in the understanding of breast cancer and its causes.

The new study, published in Nature, provides a “near-perfect picture” of the genetic processes that lead to breast cancer and opens up new possibilities for treatment and prevention of the disease.

July, 2016

A “superior” test for cervical cancer is now being offered to millions of women following a successful pilot programme in the UK.

The test, which targets HPV (human papilloma virus), is being rolled out in surgeries and clinics and should be available nationwide within two years.

July, 2016

Extended periods of sunshine may be as difficult as ever to predict during the Great British summer – but that gives us all the more reason to keep in mind our risk of skin cancer.

When the weather is hot and sunny, the intense UV radiation from the sun’s rays can pose a very real threat and adequate sun protection is required. Variable weather can lull us into a false sense of security, however, with cloudy or rainy periods making is feel we don’t need to bother with sun protection. Even short periods of exposure can put us at risk, however.

June, 2016

Delegates from leading businesses gathered at Home House in London on 31 May 2016 to hear well-known experts discuss the current cancer epidemic and why it’s crucial for employers to address cancer in the workplace. 

June, 2016

A new report suggests that over the next two decades the UK could be hit by 670,000 new cases of cancer that have an entirely preventable cause.

The report, issued by the Obesity Health Alliance, looked at the impact obesity has on the nation’s health and concluded that more than 7.6 million new cases of disease linked to being overweight or obese could be diagnosed in the UK during the next 20 years. This includes an additional 4.62 million cases of type 2 diabetes and 1.63 million cases of coronary heart disease, as well as the predicted 670,000 new cases of cancer. In 2035 alone, around 440,000 new cases of disease could be caused by being overweight and obese in the UK.

June, 2016

Under the current legislation you don’t have to tell your boss if you have cancer. The worry for many people is what it means for their career - will they be written off, never again seen as an effective, ‘can-do’ employee? Being open about such a serious condition is important when it comes to getting support and understanding, making sure you get the flexibility you need from an employer.

June, 2016

20 June 2016 - Cigna UK HealthCare Benefits (Cigna) and SkinHealth UK have formed an alliance to offer Cigna customers skin cancer diagnostics beginning June 2016. This new service offers customers rapid access to skin cancer specialists.

New research shows that 25 percent of all cancer sufferers see their General Practitioner (GP) three times before being referred for further tests.¹ With Cigna’s new service, customers can self-refer for a skin cancer diagnostic appointment within five working days. 

June, 2016

To mark Cervical Cancer Awareness Week – a UK-wide initiative led by Jo's Cervical Cancer Trust – Mr Jullien Brady, Clinical Advisor for Check4Cancer, answers some key questions about cervical cancer, detection and treatment.

June, 2016

A new study funded by Cancer Research UK has shown that people are not reporting cancer alarm symptoms because they are worried they may be wasting their GP’s time.

The study, published in the British Journal of General Practice, explored the reasons why some people are more likely to worry about wasting a GP’s time and delay reporting possible cancer symptoms. Some felt that long waiting times indicated GPs were so busy they “shouldn’t bother making an appointment unless symptoms seemed very serious”. There was a perception that the GP “wasn’t interested”.

May, 2016

Employers are being left exposed to the fallout from cancer cases by a lack of specific planning, support and management according to the results of a new survey issued to 500 HR professionals.

71% of HR managers surveyed say they don’t have any policies in place for communications or management of employees with a cancer diagnosis. 48% believe line managers in their organisation are unprepared when it comes to managing staff with cancer, with 13% saying they don’t think managers are prepared ‘at all’. At the same time, over half think the line manager relationship is the most important form of support for employees with cancer.

May, 2016

Gordon Wishart, Professor of Cancer Surgery and Chief Medical Officer of Check4Cancer has called for self-examination to be a priority amongst women as part of the fight against breast cancer.

“Women themselves are the first line of defence when it comes to breast health,” he says, “not only by moderating lifestyle factors that affect their risk but because they are best placed to detect unusual changes in their own bodies. So often cancer makes us feel that we are not in control of our health, but self-checking gives some of that sense of control back. More importantly, it also saves lives: around 90% of breast lumps are found by women themselves.”

May, 2016

To mark Skin Cancer Awareness Month (May), Per Hall, Clinical Advisor for SkinHealth UK, talks about skin cancer awareness, risk factors and how our attitudes need to change.

People have become much more aware of the dangers of UV exposure in recent years, and the precautions we can take against it are relatively simple – but are people as aware as they should be?

May, 2016

A new survey carried out by a leading prostate cancer charity has revealed a serious lack of awareness among men about their own bodies and their risk of prostate cancer, despite the fact that one man every hour dies from the disease.

The research carried out by Prostate Cancer UK, which surveyed almost 2,000 men, showed that most had no idea what the gland did or even that they had one. 92% of them did not know that the prostate helps make the fluid sperm swims in and contains muscles for ejaculation, whilst more than half did not know where it was in their body. 17% of those surveyed were unaware of it altogether.

April, 2016

To mark Bowel Cancer Awareness Month Justin Davies, Clinical Adviser for Check4Cancer, talks about new developments in screening techniques, risk factors and why all those who are invited should take the test.

March, 2016

Increasing pressure on NHS resources and the squeeze on funding means employees face more limited services and potential delays in treatment if completely reliant on free health services for themselves and their families. And this, inevitably, means a knock-on effect for employers. But this is where employers can step up to the plate – and it makes the benefits and health and wellbeing support provided all the more crucial.

Here are five things you need to know about the NHS and employee health.

March, 2016

To mark Prostate Cancer Awareness Month (March) Vincent Gnanapragasam, Clinical Director for ProstateHealth UK, talks about the importance of screening and how greater awareness can help save lives.

February, 2016

New figures released by Cancer Research UK have shown a 12% increase in the rate of cancer since the mid-90s.

More than 352,000 people are now diagnosed with cancer in the UK each year, compared with more than 253,000 people getting the disease every year two decades before (a rise from 540 per 100,000 people in 1993-1995 to 603 per 100,000 in 2011-2013).

February, 2016

Whilst we often complain about grey winter days, winter sun can bring hidden dangers – especially for those enjoying winter sports.

According to Cancer Research UK there is strong evidence to show that overexposure to ultraviolet (UV) radiation is the main preventable cause of skin cancers – both malignant melanoma and non- melanoma skin cancers (NMSC). Sunbeds produce artificial UV radiation, but the sun is the principal source of natural UV radiation. A study published in 2011 estimated that 86% of melanomas in the UK (around 11,100 cases) every year are linked to too much exposure to sunlight and sunbed use.

February, 2016

1. Globally, one in every eight deaths is caused by cancer – more than malaria, tuberculosis and AIDS combined. According to figures from Cancer Research UK, 338,623 people in the UK were diagnosed with cancer in 2012 – that’s 590.5 people per 100,000 of the population. There were also 161,823 deaths from cancer (168.6 people per 100,000 of the population).

2. Cancer is increasing: one in two UK people born after 1960 will be diagnosed with some form of cancer during their lifetime. Cancers of the breast, lung, prostate and bowel account for over half (53%) of all new cancer cases.

February, 2016

2015 proved a turbulent year for national and international politics – but the news that dominated the New Year was cancer, with musicians Lemmy and David Bowie and actor Alan Rickman all dying of the disease within days of each other.

“These deaths occurring so close together were widely regarded as a tragic coincidence,” says Gordon Wishart, Professor of Cancer Surgery and Medical Director of Check4Cancer. “Unfortunately they are indicative of general trends, and we are likely to see this more often. Celebrity cases can help focus attention on efforts to combat the disease, but the important message we need to get across is that cancer affects us all. One in two people born after 1960 will be diagnosed with some form of cancer during their lifetime, so if it is not us, it will be someone we know.”

January, 2016

A newly launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.

The PANTERA study, led by Sheffield Hallam University, will focus on 50 men who have the disease, but whose cancer has not spread. This trial – believed to be the first of its kind in the world – would aim to test whether regular exercise can help keep prostate cancer from spreading to other parts of the body and could be a viable NHS treatment.

January, 2016

To mark Cervical Cancer Prevention Week – a UK-wide initiative led by Jo's Cervical Cancer Trust – Mr Jullien Brady, Clinical Advisor for Check4Cancer, talks about the importance of screening, HPV and the challenge of getting more women to attend their tests.

January, 2016

GeneHealth UK (part of the Check4Cancer Ltd group of companies) is delighted to announce the appointment of Dr Antonis Pantazis as Clinical Advisor - Cardio.

December, 2015

Getting cancer is often seen as being down to bad genes or bad luck, but new research shows that as many as nine out of ten cancers are due to environmental or lifestyle factors.

The study, carried out by scientists from Stony Brook University in New York and published in the journal Nature, overturns the so-called ‘bad luck hypothesis’ – the idea that many cancers are due to random cell mutations. In January 2015, a study from Johns Hopkins University had suggested that 65% of cancers were driven by random mistakes in cell division and were therefore inevitable, and completely outside our control.

December, 2015

Professor Gordon Wishart, Professor of cancer surgery and Medical Director at Check4Cancer, explores the crucial role cancer awareness and screening programmes in the workplace play in raising awareness of cancer.

Incidences of cancer are steadily rising with latest estimates suggesting that over 750,000 people of working age are living with a cancer diagnosis in the UK.

December, 2015

There are few workplaces that have not been in some way affected by cancer. Many of us will have participated in some form of fundraising as a direct result of a colleague’s diagnosis, and sadly such instances are becoming more common.

December, 2015

Most of us are aware of cancer risks associated with specific working environments. Asbestos is widely known as a highly dangerous, cancer-causing substance, and the dangers of pollutants or exposure to sunlight are broadly understood by those who routinely work with them – and with employers fully expected to offer necessary precautions. But how many of us are aware that the one thing we do most often at work, simply sitting down, is increasing our risk of cancer – and to such an extent that it has prompted US experts to announce “sitting is the new smoking”?

© 2020 Check4Cancer, Lower Court 3-4, Copley Hill Business Park, Cambridge Road, Cambridge, CB22 3GN
Registered in England and Wales. Company registration number 08866941